InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (17 ops.)
Insider track record
OtherDisclosed buys
1
Disclosed sells
17
T+90 hit rate
50%
T+90 mean return
+43.9%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Matsuda Masaru, See Remarks. Director active across 2 companies, notably Arcutis Biotherapeutics, Inc.. In total, 32 filings have been recorded. Split: 1 buy · 17 sells. Total volume traded: €1.2m. History available since 4 September 2021. The latest transaction was disclosed on 4 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations32 total
7,372 shares@ US$23.26960.0055% mcap20.3% of flowCommon StockSEC:0001798679-26-000002
7,372 shares@ US$23.26960.0055% mcap20.3% of flowCommon StockSEC:0001798679-26-000002:0
37,000 shares0Common StockSEC:0001628280-26-014326:0
37,000 shares0Common StockSEC:0001628280-26-014326
7,983 shares@ US$25.498423.7% of flowCommon StockSEC:0001628280-26-005582
7,983 shares@ US$25.49840.0064% mcap23.7% of flowCommon StockSEC:0001628280-26-005582:0
1,657 shares@ US$30.236.0% of flowCommon StockSEC:0001798679-25-000007
1,657 shares@ US$30.230.0016% mcap6.0% of flowCommon StockSEC:0001798679-25-000007:0
6,330 shares@ US$14.32666.5% of flowCommon StockSEC:0001787306-25-000116:0
5,030 shares@ US$15.19955.6% of flowCommon StockSEC:0001787306-25-000086:0
34,000 shares0Common StockSEC:0001787306-25-000038:0
8,338 shares@ US$12.708.5% of flowCommon StockSEC:0001787306-25-000017:0
4,000 shares@ US$1.6920.5% of flowCommon StockSEC:0001787306-24-000168:0
Ideal exit: 25 Feb 2025 (T+270)
4,875 shares0Common StockSEC:0001787306-24-000159:0
1,775 shares@ US$9.68471.3% of flowCommon StockSEC:0001787306-24-000159:1
5,015 shares@ US$8.68423.3% of flowCommon StockSEC:0001787306-24-000145:0
5,220 shares@ US$9.01613.6% of flowCommon StockSEC:0001787306-24-000118:0
4,875 shares0Common StockSEC:0001787306-24-000083:0
5,016 shares@ US$8.73783.4% of flowCommon StockSEC:0001787306-24-000069:0
3,760 shares@ US$11.12123.2% of flowCommon StockSEC:0001787306-24-000042:0
74,000 sharesCommon StockSEC:0001787306-24-000018:0
28,000 shares0Common StockSEC:0001787306-24-000008:0
4,875 shares0Common StockSEC:0001787306-23-000126:0
1,850 shares@ US$1.9790.3% of flowCommon StockSEC:0001787306-23-000126:1
4,875 shares0Common StockSEC:0001787306-23-000066:0
25 of 32 declarations
About Matsuda Masaru
Masaru Matsuda is involved in various functions at Arcutis Biotherapeutics, Inc. and Halozyme Therapeutics, Inc. His role includes specific responsibilities that contribute to the development and strategy of the companies. His expertise is an asset to the organization.
